Inventor

STINCHCOMB DAN T

US50 patents

⚠️ This page may combine multiple inventors who share the name “STINCHCOMB DAN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STINCHCOMB DAN T

RIBOZYME PHARM INC

HIV nef targeted ribozymes

Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor

C-myb targeted ribozymes

Ribozyme treatment of diseases or conditions related to levels of NF-κB

Nucleic acid based inhibition of CD40

Ribozymes targeted to APO(a) RNA

B7-1 targeted ribozymes

HIV targeted ribozymes

TNF-α ribozymes

Method of reducing stromelysin RNA via ribozymes

IL-5 targeted ribozymes

Intercellular adhesion molecule-1 (ICAM-1) ribozymes

Interleukin-2 receptor gamma-chain ribozymes

Stromelysin targeted ribozymes

Rel a targeted ribozymes

Method and reagent for inhibiting human immunodeficiency virus replication

Enzymatic nucleic acids that cleave C-fos

Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (CAM-1)

Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)

TAKEDA VACCINES INC

Compositions, methods and uses for dengue virus serotype-4 constructs

Compositions and methods for rapid immunization against dengue virus

Compositions and methods for dengue virus chimeric constructions in vaccines

Compositions and methods for dengue virus chimeric constructions in vaccines

Compositions, methods and uses for dengue virus serotype-4 constructs

Compositions and methods for live, attenuated alphavirus formulations

Compositions and methods for live, attenuated alphavirus formulations

Compositions and methods for dengue virus chimeric constructs in vaccines

Compositions and methods for administration of vaccines against dengue virus

Compositions, methods and uses for inducing viral growth

Compositions, methods of administration and uses for trivalent dengue virus formulations

STINCHCOMB DAN T

Methods and compositions for live attenuated viruses

Compositions and methods for rapid immunization against dengue virus

Compositions, methods and uses for inducing viral growth

Compositions and methods for dengue virus chimeric constructs in vaccines

Compositions and methods for administration of vaccines against dengue virus

Compositions, methods and uses for poxvirus elements in vaccine constructs

Compositions, methods and uses for expression of enterobacterium-associated peptides

Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

HESKA CORP

Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Delivery method for recombinant raccoon poxvirus

Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Cationic lipid-mediated enhancement of nucleic acid immunization of cats

IGM BIOSCIENCES INC

Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof

(unassigned)

C-myb ribozymes having 2&#39;-5&#39;-linked adenylate residues

Ribozymes targeted to apo(a) mRNA

DIMENSIONAL PHARM INC

Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides

DIMENSIONAL PHARMACEUTICALS 3

1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides

INVIRAGEN INC

Compositions, methods and uses for dengue virus serotype-4 constructs

BRANDT KEVIN S

Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof

C-myb ribozymes having 2'-5'-linked adenylate residues